Núria Reig
Direttore Tecnico/Scientifico/R&S presso SOM Innovation Biotech SA
Provenienza dei contatti di primo grado di Núria Reig
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
University of Barcelona
48
| College/University | Other Consumer Services | 48 |
SOM Innovation Biotech SA
 SOM Innovation Biotech SA Pharmaceuticals: MajorHealth Technology SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Núria Reig tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| CHEVRON CORPORATION | Integrated Oil | Private Equity Investor | |
Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona
 Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona Savings BanksFinance Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona operates as a banking foundation. It offers retail banking services such as savings accounts, deposits, pension, and insurance, as well as private banking and financial advisory, including personalized investment strategies and portfolio management. The company was founded in 1904 and is headquartered in Barcelona, Spain. | Savings Banks | Director/Board Member Corporate Officer/Principal Chief Executive Officer | |
| ALLIANZ SE | Multi-Line Insurance | Corporate Officer/Principal | |
| BANCO BPI | Regional Banks | Director/Board Member | |
Caixabank Asset Management SGIIC SA
 Caixabank Asset Management SGIIC SA Investment ManagersFinance Caixabank Asset Management SGIIC SA (CAM) is the wholly-owned asset management subsidiary of Caixabank SA (MP: CABK, ADR: CAIXY) in Spain. The firm was established in 1983 and is headquartered in Barcelona. CAM develops investment solutions adapted to the profile of each client. They manage a wide range of funds, SICAVs and discretionary management portfolios. In 2016, they reaffirm their commitment to the UN Global Compact by signing the United Nations Principles for Responsible Investment (UNPRI). | Investment Managers | Portfolio Manager-Equities | |
| ORYZON GENOMICS S.A. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
| Indiana University | College/University | Graduate Degree | |
Noucor Health SA
 Noucor Health SA Miscellaneous Commercial ServicesCommercial Services J. Uriach y Cia SA manufactures and markets pharmaceutical products. It offers consumer health products, including over-the-counter drugs, food supplements, personal health and wellbeing products, and nutricosmetic products. The company was founded by Juan Uriach Feliu in 1838 and is headquartered in Barcelona, Spain. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Navarra | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
| Universidade Técnica de Lisboa | College/University | Undergraduate Degree | |
| London Business School | College/University | Masters Business Admin | |
| Escuela Superior de Administración y Dirección de Empresas | College/University | Graduate Degree Masters Business Admin Undergraduate Degree Graduate Degree Graduate Degree | |
| Ramon Llull University | College/University | Undergraduate Degree Director/Board Member Graduate Degree Masters Business Admin | |
| CAIXABANK, S.A. | Regional Banks | Corporate Officer/Principal Director/Board Member General Counsel Director/Board Member | |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor Private Equity Investor | |
Inveready Asset Management SGEIC SA
 Inveready Asset Management SGEIC SA Investment ManagersFinance Inveready Asset Management SGEIC SA (Inveready) is a private equity and venture capital subsidiary of Inveready Capital Co. SL founded in 2008 by Joseph Maria Echarri Torres. The firm is headquartered in San Sebastian, Spain. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Caixa Capital Risc SGEIC SA
 Caixa Capital Risc SGEIC SA Investment ManagersFinance Caixa Capital Risc SGEIC SA (Caixa Capital Risc) is a venture capital armof Criteria Caixa SA founded in 2002. The firm is headquartered in Barcelona, Spain with additional offices in Madrid. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor | |
Allianz Insurance Co.
 Allianz Insurance Co. Multi-Line InsuranceFinance Part of Allianz SE, Allianz Insurance Co. provides insurance services. The company is based in Burbank, CA. | Multi-Line Insurance | Corporate Officer/Principal | |
Palau Pharma SA
 Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Fira Internacional de Barcelona
 Fira Internacional de Barcelona Miscellaneous Commercial ServicesCommercial Services Fira Internacional de Barcelona organizes trade shows and fairs, as well as corporate and socio-cultural events. It offers catering, logistics, transportation, accommodations, registration services for participants and guests. The company was founded in 1932, and is headquartered in Barcelona, Spain. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Allianz Seguros SA
 Allianz Seguros SA Multi-Line InsuranceFinance Allianz Seguros SA provides insurance and reinsurance services. Its solutions include automotive, life, health, transport, construction, residence, corporate, industrial risks, agribusiness, and others. The company was founded on October 29, 1929 and is headquartered in Sao Paulo, Brazil. | Multi-Line Insurance | Director/Board Member | |
Agrasys SL
 Agrasys SL BiotechnologyHealth Technology Agrasys SL develops and commercialize crops and cereals. It offers Tritordeum, a non genetic modification cereals and developed for human nutrition. The company was founded in 2005 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Eagle Eye Pozuelo SL
 Eagle Eye Pozuelo SL Real Estate DevelopmentFinance Eagle Eye Pozuelo SL operates as shopping center. It provides restaurants, saloons, pharmacy, shops, and games. The company was founded on March 03, 2006 and is headquartered in Madrid, Spain. | Real Estate Development | Director/Board Member | |
ADman Interactive SL
 ADman Interactive SL Information Technology ServicesTechnology Services ADman Interactive SL provides video streaming platform. It offers video distribution for instream, out stream and native video. Its products include Intext, In-Banner, I-Spot, and native video. The company was founded by Josep Maria Tribó Capdevila, Marcos David Luengo Sánchez and Victor Sala Gracia in 2010 and is headquartered in Barcelona, Spain. | Information Technology Services | Chief Executive Officer Founder | |
| Universitat Autònoma de Barcelona | College/University | Masters Business Admin Graduate Degree | |
Ability Pharmaceuticals SL
 Ability Pharmaceuticals SL BiotechnologyHealth Technology Ability Pharmaceuticals SL operates as a clinical stage drug discovery and development biopharmaceutical firm. It develops human therapeutics to treat cancer and other indications with unmet medical needs. The company was founded by Carles Domènech Garcia Jordi Espadaler Mazo in November 2009 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
| La Caixa Foundation | Director/Board Member Director/Board Member Director/Board Member | ||
| IFFE FUTURA, S.A. | Real Estate Investment Trusts | Director/Board Member | |
Cegal Group AS
 Cegal Group AS Information Technology ServicesTechnology Services Part of Norvestor Equity AS, Cegal Group AS is a provider of hybrid cloud solutions, software and consulting services in IT, business, geoscience and data management. The company is based in Sandnes, Norway. The Norwegian company was founded in 2010. Dagfinn Ringås has been the CEO of the company since 2020. | Information Technology Services | Director/Board Member | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
Zera Intein Protein Solutions SL
 Zera Intein Protein Solutions SL BiotechnologyHealth Technology Zera Intein Protein Solutions SL develops and commercializes biomedical technologies, with applications in the biotechnological, pharmaceutical, veterinary and industrial sectors. Its proprietary technologies include Zera and Splittera. Zera technology is composed of self-assembler peptides for DNA vaccines, carrier-free enzyme immobilization, and biopharmaceutical protein production. Splittera refers to Split Intein technology which includes trans-splicing, cyclization, and cleavage reactions. The company was founded on January 30, 2015 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Executive Officer Director/Board Member | |
Innoup Farma SL
 Innoup Farma SL BiotechnologyHealth Technology InnoUp Farma SL develops nanotechnology-based solutions for the administration of oral drugs. It offers anti-cancer drugs with low oral bioavailability. The company was founded by Maite Agueros Bazo, Manuel Rodriguez Mariscal and Juan Manuel Irache Garreta and is headquartered in Noain, Spain. | Biotechnology | Director/Board Member | |
Avizorex Pharma SL
 Avizorex Pharma SL Medical/Nursing ServicesHealth Services Avizorex Pharma SL develops drugs for the treatment of the dry eye disease. The company was founded by Carlos Belmonte and Sauri Patrick Tresserras in July, 2013 and is headquartered in Barcelona, Spain. | Medical/Nursing Services | Director/Board Member | |
Allianz Technology SL
 Allianz Technology SL Information Technology ServicesTechnology Services Part of Allianz SE, Allianz Technology SL is a Spanish company that provides information technology and computer services. The company is based in Barcelona, Spain. | Information Technology Services | Director/Board Member | |
| PARLEM TELECOM COMPANYIA DE TELECOMUNICACIONS, S.A. | Wireless Telecommunications | Director/Board Member Director/Board Member | |
Lanai Partners SL
 Lanai Partners SL Investment ManagersFinance Lanai Partners SL (Lanai Partners) is a venture capital firm founded in 2016 by Jeroen Merchiers, Rubén Ferreiro, Guillermo Llibre and Mar Alarcón The firm is headquartered in Barcelona, Spain. | Investment Managers | Private Equity Investor Private Equity Investor | |
AptaTargets SL
 AptaTargets SL Pharmaceuticals: MajorHealth Technology AptaTargets SL is a biopharmaceutical company based in Madrid, Spain that focuses on developing therapeutic applications based on aptamer technology. The Spanish company is currently developing aptoll, an immune modulator that blocks the activation of tlr4 in a stroke, representing a novel approach to treat ischemic stroke in the acute phase. It could also be administered in patients up to 48 hours after the stroke. AptaTargets targets indications where inflammation causes significant damage through clinical studies and successful preclinical development. The company was founded in 2014 by David Segarra and María Eugenia Zarabozo, with David Segarra serving as the CEO since then. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biotechnology Development for Industry in Pharmaceuticals SLU
 Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Miscellaneous Commercial Services | Director/Board Member | |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
AmacaThera, Inc.
 AmacaThera, Inc. Medical SpecialtiesHealth Technology AmacaThera, Inc. is biotechnology company, which engages in the development and commercialization of injectable hydrogel platform technology. Its platform addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. The company was founded by Molly S. Soichet and Mike Cooke and is headquartered in Toronto, Canada. | Medical Specialties | Director/Board Member | |
| EDESA BIOTECH, INC. | Pharmaceuticals: Major | Director/Board Member | |
Konstel Holding AS
 Konstel Holding AS Engineering & ConstructionIndustrial Services Konstel Holding AS invests, owns, operates, and develops companies in the electrical industry. The company was founded on April 9, 2019 and is headquartered in Oslo, Norway. | Engineering & Construction | Chairman | |
Oxolife SL
 Oxolife SL BiotechnologyHealth Technology Oxolife SL operates as an biotech company focused on treating female infertility. The company was founded by Agn?s Arbat and Ignasi Canals in 2013 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
| ASPY GLOBAL SERVICES, S.A. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Connecta Therapeutics SL
 Connecta Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Connecta Therapeutics SL is an innovation-oriented, R&D-intensive organization committed to developing innovative treatments for patients. Connecta Therapeutics is based in Barcelona, ES. The Spanish company strongly believes in improving the lives of patients and their families and understands the importance of teamwork and collaboration to achieve their goals. The company was founded in 2019 by Josep Prous, David Prous, and Jordi Fàbrega. Jordi Fàbrega has been the CEO since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
| ESADE Business School | College/University | Graduate Degree Undergraduate Degree | |
Aimbot AS
 Aimbot AS Financial ConglomeratesFinance Aimbot AS provides investment services. The private company is based in Oslo, Norway. and has subsidiaries in Norway. The Norwegian company was founded in 2021. The CEO is Odd Nymark. | Financial Conglomerates | Chairman | |
Antalgenics SL
 Antalgenics SL BiotechnologyHealth Technology Antalgenics SL is a Spanish biotechnological company that specializes in discovering and developing new bioactive molecules for biomedical and dermocosmetic applications. The company is based in Alicante, Spain. The company offers customized R & D services to design and develop projects according to the client's needs. The company's focus is on developing novel therapeutic leads, primarily for the treatment of psoriatic pruritus and psoriatic comorbidities. Antalgenics was founded in 2015, and the CEO is Philipp Tsolakis. | Biotechnology | Director/Board Member | |
| AB-BIOTICS, S.A. | Pharmaceuticals: Other | Director/Board Member Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
| Spagna | 38 |
| Stati Uniti | 4 |
| Norvegia | 4 |
| Portogallo | 3 |
| Canada | 3 |
Settori
| Finance | 16 |
| Health Technology | 16 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Technology Services | 4 |
Posizioni
| Director/Board Member | 141 |
| Corporate Officer/Principal | 63 |
| Undergraduate Degree | 38 |
| Private Equity Investor | 32 |
| Graduate Degree | 28 |
Contatti più connessi
- Borsa valori
- Insiders
- Núria Reig
- Connessioni Società
